Cidara Therapeutics Inc (CDTX)

Aug 09, 2025

A Quick Look at Today's Ratings for Cidara Therapeutics(CDTX.US), With a Forecast Between $66 to $74 - 富途牛牛

Aug 09, 2025

Aug 09, 2025

Cidara (CDTX) Q2 Cash Surges 163% - AOL.com

Aug 09, 2025

Aug 08, 2025

Cidara Therapeutics price target raised to $74 from $54 at Needham - TipRanks

Aug 08, 2025

Aug 08, 2025

Guggenheim raises Cidara Therapeutics stock price target to $70 on FDA meeting progress - Investing.com Canada

Aug 08, 2025

Aug 08, 2025

Cidara Therapeutics Rallies On Promising Flu Drug Progress - Finimize

Aug 08, 2025

Aug 08, 2025

Cidara Therapeutics Reports Positive Trial Results and Financial Growth - TipRanks

Aug 08, 2025

Aug 08, 2025

Earnings call transcript: Sidera Therapeutics’ Q2 2025 innovation focus - Investing.com

Aug 08, 2025

Aug 08, 2025

Cidara Therapeutics: Q2 Earnings Snapshot - Manistee News Advocate

Aug 08, 2025

Aug 08, 2025

Cidara Therapeutics stock price target raised to $66 at Citizens JMP - Investing.com Australia

Aug 08, 2025

Aug 08, 2025

Cidara Therapeutics Inc (CDTX) Q2 2025 Earnings Call Highlights: Promising Clinical Trial ... - Yahoo Finance

Aug 08, 2025

Aug 07, 2025

Cidara Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 07, 2025

Aug 07, 2025

Transcript : Cidara Therapeutics, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener

Aug 07, 2025

Aug 07, 2025

Cidara Therapeutics reports Q2 EPS ($1.65), consensus ($1.82) - TipRanks

Aug 07, 2025

Aug 07, 2025

Cidara Therapeutics Q2 net loss narrows - MarketScreener

Aug 07, 2025

Aug 07, 2025

Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results - GlobeNewswire

Aug 07, 2025

Aug 07, 2025

Spero leads infectious disease gains with 252% stock jump - BioWorld MedTech

Aug 07, 2025

Aug 06, 2025

RBC Capital raises Cidara Therapeutics stock price target to $115 on market potential - Investing.com Canada

Aug 06, 2025

Aug 06, 2025

Cidara Therapeutics price target raised to $115 from $75 at RBC Capital - TipRanks

Aug 06, 2025

Aug 05, 2025

Cidara Therapeutics Inc expected to post a loss of $2.00 a shareEarnings Preview - TradingView

Aug 05, 2025

Aug 05, 2025

Cidara Therapeutics CDTX Q2 2025 Earnings Preview Upside Potential on Analyst Optimism - AInvest

Aug 05, 2025

Aug 03, 2025

Is Cidara Therapeutics Inc. stock overvalued or undervaluedCapitalize on market momentum for maximum gains - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Should I hold or sell Cidara Therapeutics Inc. stock in 2025Achieve breakthrough gains with expert advice - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Cidara Therapeutics Inc. Stock Analysis and ForecastInvest smarter with data-backed insights - Jammu Links News

Aug 03, 2025

Aug 03, 2025

How strong is Cidara Therapeutics Inc. company’s balance sheetGet daily updates on promising stocks - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What institutional investors are buying Cidara Therapeutics Inc. stockBuild a diversified portfolio for risk management - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What makes Cidara Therapeutics Inc. stock price move sharplyRecord-breaking capital gains - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Is Cidara Therapeutics Inc. a good long term investmentInvest with confidence backed by data - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What are analysts’ price targets for Cidara Therapeutics Inc. in the next 12 monthsDynamic portfolio growth - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What is the risk reward ratio of investing in Cidara Therapeutics Inc. stockAchieve rapid wealth accumulation through smart investing - Jammu Links News

Aug 03, 2025

Aug 02, 2025

What is the dividend policy of Cidara Therapeutics Inc. stockFree Trading Psychology Coaching - Jammu Links News

Aug 02, 2025

Aug 02, 2025

What are Cidara Therapeutics Inc. company’s key revenue driversAchieve rapid capital gains with smart investing - Jammu Links News

Aug 02, 2025

Aug 01, 2025

Will Cidara Therapeutics Inc. Bounce From 52 Week LowTriple Digit Growth Focused Trade Plan Reviewed - metal.it

Aug 01, 2025

Jul 30, 2025

Moving Average Crossover Confirms Uptrend in Cidara Therapeutics Inc.Real Time Alerts Based on AI Prediction Triggered - metal.it

Jul 30, 2025

Jul 30, 2025

How Cidara Therapeutics Inc. stock performs during market volatilityHigh Win Rate Trading Opportunities Detected - beatles.ru

Jul 30, 2025

Jul 30, 2025

Can trapped investors hope for a rebound in Cidara Therapeutics Inc.Real-Time Trade Insights Spark Market Reactions - metal.it

Jul 30, 2025

Jul 29, 2025

Will Cidara Therapeutics Inc. stock split in the near futureInvestment Strategy With Predictable Gains Outlined - metal.it

Jul 29, 2025

Jul 29, 2025

Candidemia Market Analysis and Forecast Report 2025-2035 Featuring Pfizer, Cidara Therapeutics, Scynexis, Merck, Basilea Pharmaceutica, Lupin Pharmaceuticals, Astellas PharmaResearchAndMarkets.com - FinancialContent

Jul 29, 2025

Jul 28, 2025

Why Cidara Therapeutics Inc. stock attracts strong analyst attentionBuy Signal Based on Chart Analysis Confirmed - metal.it

Jul 28, 2025

Jul 28, 2025

Why is Cidara Therapeutics Inc. stock attracting strong analyst attentionFree Market Volatility Navigation Tips - Jammu Links News

Jul 28, 2025

Jul 28, 2025

What is Cidara Therapeutics Inc. company’s growth strategySwing Trade Updates To Watch Now - jammulinksnews.com

Jul 28, 2025

Jul 28, 2025

Why Cidara Therapeutics Inc. stock attracts strong analyst attention Fundamental + Technical Combined Watchlist - metal.it

Jul 28, 2025

Jul 27, 2025

Published on: 2025-07-28 06:14:55 - Jammu Links News

Jul 27, 2025

Jul 27, 2025

How does Cidara Therapeutics Inc. compare to its industry peersDiscover breakthrough trading strategies - jammulinksnews.com

Jul 27, 2025